Department of Head and Neck Oncology & Surgery, The Netherlands Cancer Institute, Plesmanlaan, Amsterdam, The Netherlands.
J Voice. 2012 Sep;26(5):664.e25-33. doi: 10.1016/j.jvoice.2011.08.016. Epub 2011 Dec 29.
Perceptual judgments and patients' perception of voice and speech after concurrent chemoradiotherapy (CCRT) for advanced head and neck cancer.
Prospective clinical trial.
A standard Dutch text and a diadochokinetic task were recorded. Expert listeners rated voice and speech quality (based on Grade, Roughness, Breathiness, Asthenia, and Strain), articulation (overall, [p], [t], [k]), and comparative mean opinion scores of voice and speech at three assessment points calculated. A structured study-specific questionnaire evaluated patients' perception pretreatment (N=55), at 10-week (N=49) and 1-year posttreatment (N=37).
At 10 weeks, perceptual voice quality is significantly affected. The parameters overall voice quality (mean, -0.24; P=0.008), strain (mean, -0.12; P=0.012), nasality (mean, -0.08; P=0.009), roughness (mean, -0.22; P=0.001), and pitch (mean, -0.03; P=0.041) improved over time but not beyond baseline levels, except for asthenia at 1-year posttreatment (voice is less asthenic than at baseline; mean, +0.20; P=0.03). Perceptual analyses of articulation showed no significant differences. Patients judge their voice quality as good (score, 18/20) at all assessment points, but at 1-year posttreatment, most of them (70%) judge their "voice not as it used to be." In the 1-year versus 10-week posttreatment comparison, the larynx-hypopharynx tumor group was more strained, whereas nonlarynx tumor voices were judged less strained (mean, -0.33 and +0.07, respectively; P=0.031). Patients' perceived changes in voice and speech quality at 10-week post- versus pretreatment correlate weakly with expert judgments.
Overall, perceptual CCRT effects on voice and speech seem to peak at 10-week posttreatment but level off at 1-year posttreatment. However, at that assessment point, most patients still perceive their voice as different from baseline.
评估头颈部癌症患者接受同期放化疗(CCRT)后嗓音和言语的感知判断和患者感知。
前瞻性临床试验。
记录标准荷兰语文本和双音节词测试。由专家听众根据等级、粗糙度、呼吸音、乏力和紧张度对嗓音和言语质量进行评分,并在三个评估点计算言语和嗓音的综合平均意见评分。一份结构特定的研究调查问卷在治疗前(N=55)、10 周时(N=49)和 1 年时(N=37)评估患者的感知。
10 周时,嗓音感知质量受到明显影响。总体嗓音质量(平均,-0.24;P=0.008)、紧张度(平均,-0.12;P=0.012)、鼻音度(平均,-0.08;P=0.009)、粗糙度(平均,-0.22;P=0.001)和音调(平均,-0.03;P=0.041)参数随时间改善,但未超过基线水平,除 1 年后的乏力外(嗓音比基线时更乏力;平均,+0.20;P=0.03)。发音感知分析未显示出显著差异。患者在所有评估点都认为自己的嗓音质量良好(评分,18/20),但在 1 年后,大多数人(70%)认为自己的“嗓音不再像以前那样”。在 1 年与 10 周的比较中,喉下咽肿瘤组的嗓音更紧张,而非喉肿瘤的嗓音则被认为不那么紧张(平均,-0.33 和+0.07,分别;P=0.031)。患者在 10 周时嗓音和言语质量感知的变化与专家判断的相关性较弱。
总体而言,CCRT 对嗓音和言语的感知影响似乎在治疗后 10 周达到高峰,然后在 1 年后趋于稳定。然而,在该评估点,大多数患者仍认为自己的嗓音与基线时不同。